Related Experiment Video
Updated: Sep 28, 2026

Flow Cytometry Analysis of Tissue Factor Expression in Human Platelets
Published on: November 22, 2024
Observation on tissue factor pathway and some other coagulation parameters during the onset of acute cerebrocardiac
Meixia He1, Zhibin Wen, Xiaofan He
1Department of Physiology, Xiangya Hospital, Xiangya Medical College, Central South University, Changsha Hunan 410078, China.
Insights
Thrombosis drives acute myocardial infarction (AMI) and acute ischemic stroke (AIS). This study links coagulation factors like tissue factor (TF) to these events, revealing distinct patterns in AMI versus AIS.
Area of Science:
- Cardiovascular Medicine
- Hematology
- Thrombosis Research
Background:
- Thrombosis is central to acute myocardial infarction (AMI) and acute ischemic stroke (AIS).
- The precise role of coagulation factors in arterial diseases remains unclear.
- Understanding these factors is crucial for managing thrombotic events.
Purpose of the Study:
- To investigate the relationship between coagulation factors, anticoagulants, and the occurrence of AMI and AIS.
- To differentiate the coagulation profiles in patients with AMI and AIS compared to healthy individuals.
Main Methods:
- Comparative analysis of coagulation factors and inhibitors in 69 AMI patients, 71 AIS patients, and 50 healthy controls.
- Measurement of plasma activities and antigens for tissue factor (TF), tissue factor pathway inhibitor (TFPI), Factor VII (FVII:C), Factor VIII (FVIII:C), prothrombin, fibrinogen, and antithrombin III.
Main Results:
- Elevated TF and TFPI in AMI; increased TF but decreased TFPI in AIS.
- Higher FVII:C in AIS, higher FVIII:C in AMI.
- Increased prothrombin and fibrinogen, with decreased antithrombin III in both AMI and AIS groups.
- Distinct coagulation factor changes observed between AMI and AIS.
Conclusions:
- The initiation of the tissue factor (TF) pathway is associated with thrombotic events in AMI and AIS, indicating a hypercoagulable state.
- Coagulation factor profiles differ significantly between AMI and AIS, suggesting distinct pathophysiological mechanisms.
- Further research into these specific factor alterations may lead to targeted therapies.
Abstract:
It is widely recognized that thrombosis is the major event in the evolution of acute myocardial infarction (AMI) and acute ischemic stroke (AIS). But the contribution of coagulation factors to the development of ischemic arterial diseases is still not clearly established. The goal of this study was to establish the possible relationship between coagulation factors as well as anticoagulant and the onset of AMI and AIS. The study population consisted of 69 patients with AMI and 71 with AIS as well as 50 age-matched healthy volunteers. Compared with the control group, plasma tissue factor (TF) and tissue factor pathway inhibitor (TFPI) activities and both TF and TFPI antigens were significantly higher in the AMI group; plasma TF activity and antigen in AIS group were significantly increased, but the activity and antigen of plasma TFPI were significantly decreased in the AIS group. Plasma FVII coagulation (FVII:C) activity was markedly higher in patients with AIS, but not statistically different to the control in patients with AMI. FVIII coagulation (FVIII:C) activity was remarkably higher in patients with AMI but slightly lower than the control in patients with AIS. In the AMI and AIS groups, prothrombin activity and clottable fibrinogen were significantly higher and plasma antithrombin III activity was remarkably lower than the control. The results suggested that during the onset of AMI and AIS, the initiation of TF pathway would be associated with the thrombotic events and that the blood be in hypercoagulable state. But the changes of FVII:C, TFPI and FVIII:C in AMI are different from those in AIS.
Related Concept Videos
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Hemorrhagic Stroke ll: Pathophysiology
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Transient Ischemic Attack l: Introduction
Anticoagulant Drugs: Low-Molecular-Weight Heparins

